June 2, 2026
1 min read

ADHD drug delivery specialist Cingulate hit with manufacturing-related FDA rejection

Cingulate will need to take a detour to win its first FDA approval, as the agency has rejected its lead candidate over manufacturing concerns.

Leave a Reply

Your email address will not be published.

Previous Story

Amid Ebola, Hantavirus Outbreaks, Democrats Decry Trump’s Health Cuts MedNews

Next Story

Eisai whips up Alzheimer’s dietary guidance to expand nutrition program beyond cancer

Previous Story

Amid Ebola, Hantavirus Outbreaks, Democrats Decry Trump’s Health Cuts MedNews

Next Story

Eisai whips up Alzheimer’s dietary guidance to expand nutrition program beyond cancer

Latest from Blog

Go toTop